Navigation Links
Advanced Life Sciences Announces Third Quarter 2008 Financial Results
Date:11/6/2008

d clinical trial and NDA expenses 801,679 2,776,543

Other accrued expenses 1,411,523 330,441

Accrued interest payable 20,391 22,756

Short-term lease payable 8,142 7,259

Short-term notes payable - related party 2,000,000 -

Total current liabilities 14,514,875 5,822,750

Long-term lease payable 6,595 12,818

Long-term grant payable 500,000 500,000

Long-term notes payable - related party - 2,000,000

Line of credit 3,915,000 3,915,000

Total liabilities 18,936,470 12,250,568

COMMITMENTS AND CONTINGENCIES

MINORITY INTEREST - -

STOCKHOLDERS' EQUITY (DEFICIT):

Common stock, $0.01 par value - 60,000,000

shares authorized; 40,805,932 issued and

outstanding at September 30, 2008; 38,502,987

shares issued and outstanding at

December 31, 2007 408,059 385,030

Additional paid-in capital 109,416,354 106,859,532

Deficit accumulated during the

development stage (119,613,300) (99,583,588)

Total stockholders' equity (deficit) (9,788,887) 7,660,974

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

(DEFICIT) $9,147,583 $19,911,542

ADVANCED LIFE SCIENCES HOLDINGS, INC. AND SUBSIDIARY

(A Development Stage Company)

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

Three months ended

September 30,


'/>"/>
SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... (PRWEB) November 27, 2014 Spartan Bioscience ... of Food and Drug Safety (MFDS) regulatory approval for ... provides genetic results in less than 60 minutes from ... indicated as an aid for doctors to determine therapeutic ... pathway. These include some of the world’s most commonly ...
(Date:11/27/2014)... and PITTSFIELD, Massachusetts, USA (PRWEB) November 26, 2014 ... cells with more accuracy, additive systems to enable 3D ... safety by analyzing road conditions are among finalists in ... Photonics Innovation . The awards are sponsored by ... and Photonics Media . , Winners will be ...
(Date:11/26/2014)... 2014 2014 Deep Research Report ... and in-depth research report on the Ammonium Bifluoride ... definition, classification, application, and industry chain structure as ... international market analysis, including China’s domestic market as ... Asia, China, Japan etc. regions) industry analysis covering ...
(Date:11/26/2014)... 26, 2014 The announced sales of three ... is looking to expand in non-healthcare areas, says Kalorama ... market research firm says that  Siemens is the third ... survey of the IVD market , with 5.5 billion ... its composition would likely affect IVD market shares.  ...
Breaking Biology Technology:Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 2Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 3Finalists Named for 2015 Prism Awards for Photonics Innovation 2Finalists Named for 2015 Prism Awards for Photonics Innovation 3Finalists Named for 2015 Prism Awards for Photonics Innovation 4Finalists Named for 2015 Prism Awards for Photonics Innovation 5Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 2Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 3Kalorama: Sale of Three Siemens Healthcare Units Raises Questions About Firm's IVD Future 2
... New Analysis of the 104 ABPM Study Presented at the American Heart ... Association ... http://www.nicox.com , ... a new analysis of the data,from the 104 Ambulatory Blood Pressure Monitoring (ABPM) study ...
... "Horror In The Wind," has been banned by Allen Theaters of ... screen the locally produced comedy because it is too political. ... reverses the whole world,s sexual orientation. , ... Alamogordo, ...
... LOUIS, Nov. 11 At the Board of ... cash dividend of,$.13 per share. The dividend is ... on December 1, 2008., About Sigma-Aldrich: Sigma-Aldrich ... Our biochemical and organic chemical products and kits,are ...
Cached Biology Technology:NicOx' Naproxcinod Shows Highly Significant Reduction in Daytime Blood Pressure Versus Naproxen 2NicOx' Naproxcinod Shows Highly Significant Reduction in Daytime Blood Pressure Versus Naproxen 3Comedy 'Horror In The Wind' Banned In New Mexico 2Comedy 'Horror In The Wind' Banned In New Mexico 3
(Date:11/3/2014)... Researchers from Australia report that low birth weight and ... (OA)-related hip replacements in adulthood. Findings published in the ... & Research , indicate that low birth weight and ... arthroplasty due to OA as adults. , According ... of 25 are diagnosed with clinical OA. Symptoms of ...
(Date:11/2/2014)... November 2014)—In support of a bold quest to rid ... Gates Foundation today announced an award of US$156 million ... (MVI) in building new vaccines that will interrupt the ... "accelerating to zero" agenda. Such vaccines would ensure that ... called an "immunological bed net." , This approach ...
(Date:11/2/2014)... Nate Silver and Richard Feynman walk into a bar and ... may sound like the setup to some late-night nerd sketch, ... increasingly cumbersome problem in modern biology, namely, finding meaning in ... instance, the data comprisesreams of cancer mutations that genome-wide studies ... new and efficient ways to parse the signal from the ...
Breaking Biology News(10 mins):Preterm, low birth-weight babies may need new hips in adulthood 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 3New malaria vaccines to prevent infection and block transmission get a shot in the arm 4Mutant models 2Mutant models 3Mutant models 4
... thousands of years on tiny islands surrounding Australia have evolved ... their mainland cousins. Now, new research in The American ... driven by the need to have big-mouthed babies. Mainland ... cm) long, patrol swampy areas in search of frogs, their ...
... PORTLAND, Ore. (May 15, 2012)Twenty-six scientists have received a ... Psoriasis Foundation to study psoriasisthe most common autoimmune disease ... Americansand psoriatic arthritis, an inflammatory joint and tendon disease. ... $50,000 Discovery Grant, for a total of $400,000, for ...
... in gardens, burned for heat and energy, and converted into ... that includes corn, sorghum and sugarcane. Two new, independently produced ... that likely is a parent of Miscanthus giganteus , ... M. sinensis genome. The studies reveal how a ...
Cached Biology News:Big-mouthed babies drove the evolution of giant island snakes 2Big-mouthed babies drove the evolution of giant island snakes 3National Psoriasis Foundation awards more than $2 million for research 2Maps of Miscanthus genome offer insight into grass evolution 2Maps of Miscanthus genome offer insight into grass evolution 3
... Immunogen: Synthetic peptide derived from ... rat mouse dog and orangutang occludin ... human occludin protein. Reactivity: Human ... Reactivity with rat mouse dog and ...
...
Anti-ZFP-38/RU49 Family: Zinc Finger Peptide Sequence: SVKVEDKDFPSTCSKK...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
Biology Products: